Anagenics - 1H FY26 Result Highlights
| Stock | Anagenics Ltd (AN1.ASX) |
|---|---|
| Release Time | 25 Feb 2026, 8:48 a.m. |
| Price Sensitive | Yes |
Anagenics Reports Maiden Profit in 1H FY26
- Retained 90% of Revenue vs prior corresponding period
- Improved Gross Profit margin by 280bps
- Reduced Operating Expenses by 44%
Anagenics Ltd (ASX:AN1) has reported its financial results for the six months ended 31 December 2025 (1H FY26), highlighting a material turnaround in earnings. Following the Company's recent restructure, Anagenics has retained 90% of Revenue versus the prior corresponding period, improved Gross Profit margin by 280bps, and reduced Operating Expenses by 44%. This has resulted in a maiden profit of $127k in 1H FY26, compared to a $464k loss in 1H FY25. Cash Flows have also improved materially, with the $0.6m Operating Cash Outflow reported during 1H FY26 being a significant improvement from the $1.2m Operating Cash Outflow in 1H FY25. The resolution of outstanding creditors drove the negative Operating Cash Flow during 1H FY26, and this impact is expected to end in 2H FY26. The disposal of non-core business units, such as the loss-making Face MediGroup, has reduced Group overheads and complexity, contributing to annualised cost savings of $2.5m. The Group also recently achieved an exit of 55 Clarence St via sublease, saving an additional ~$100k in 2H FY26. Over the past six months, Anagenics has achieved a 20% reduction in liabilities, largely via a 43% improvement in creditor balances, resulting in a 24% increase in Net Assets. Anagenics has also successfully completed a $2.25m two-tranche equity raise, with the funds to be used for brand expansion, value-accretive business opportunities, debt retirement, working capital, and placement costs. Key growth developments include the Company's agreement with Sydney-based York Street Brands for access to Anagenics' hair regrowth technology and products, targeting a minimum $4.4m over 10 years and currently runrating $9m, which delivered $500k of royalties in 1H FY26.
Management and the board remain focused on further building on these gains in order to entrench long-term profitability for the benefit of our strategic partners and shareholders.